DA-3803

· Dong-A Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DA-3803, covering 2013-05-16 to 2013-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial Comparing the Efficacy and Safety of DA-3803 and Ovidrel [Phase 3]